VE-cadherin: At the front, center, and sides of endothelial cell organization and function

Current Opinion in Cell Biology

Volumn 22, Issue 5, 2010, Pages 651-658

  Harris, Elizabeth S ^a   Nelson, W James ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MYOSIN LIGHT CHAIN 2; RAC1 PROTEIN; RHO KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; WNT PROTEIN;

ADHERENT CELL; ANGIOGENESIS; CELL ADHESION; CELL CYCLE PROGRESSION; CELL FUNCTION; CELL JUNCTION; CELL SURFACE; ENDOTHELIUM CELL; HUMAN; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, CD; CADHERINS; CELL-MATRIX JUNCTIONS; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 77957233298     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2010.07.006     Document Type: Review

References (74)

1. Weis S.M., Cheresh D.A. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005, 437:497-504.
2. Dejana E., Tournier-Lasserve E., Weinstein B.M. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 2009, 16:209-221.
3. Lampugnani M.G., Resnati M., Raiteri M., Pigott R., Pisacane A., Houen G., Ruco L.P., Dejana E. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 1992, 118:1511-1522.
4. Wallez Y., Huber P. Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta 2008, 1778:794-809.
5. Hartsock A., Nelson W.J. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 2008, 1778:660-669.
6. Salomon D., Ayalon O., Patel-King R., Hynes R.O., Geiger B. Extrajunctional distribution of N-cadherin in cultured human endothelial cells. J Cell Sci 1992, 102(Pt 1):7-17.
7. Gerhardt H., Wolburg H., Redies C. N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken. Dev Dyn 2000, 218:472-479.
8. Carmeliet P., Lampugnani M.G., Moons L., Breviario F., Compernolle V., Bono F., Balconi G., Spagnuolo R., Oosthuyse B., Dewerchin M., et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 1999, 98:147-157.
9. Gory-Faure S., Prandini M.H., Pointu H., Roullot V., Pignot-Paintrand I., Vernet M., Huber P. Role of vascular endothelial-cadherin in vascular morphogenesis. Development 1999, 126:2093-2102.
10. Montero-Balaguer M., Swirsding K., Orsenigo F., Cotelli F., Mione M., Dejana E. Stable vascular connections and remodeling require full expression of VE-cadherin in zebrafish embryos. PLoS One 2009, 4:e5772.
11. Corada M., Mariotti M., Thurston G., Smith K., Kunkel R., Brockhaus M., Lampugnani M.G., Martin-Padura I., Stoppacciaro A., Ruco L., et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A 1999, 96:9815-9820.
12. Gotsch U., Borges E., Bosse R., Boggemeyer E., Simon M., Mossmann H., Vestweber D. VE-cadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci 1997, 110(Pt 5):583-588.
13. Cattelino A., Liebner S., Gallini R., Zanetti A., Balconi G., Corsi A., Bianco P., Wolburg H., Moore R., Oreda B., et al. The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J Cell Biol 2003, 162:1111-1122.
14. Oas R.G., Xiao K., Summers S., Wittich K.B., Chiasson C.M., Martin W.D., Grossniklaus H.E., Vincent P.A., Reynolds A.B., Kowalczyk A.P. p120-Catenin is required for mouse vascular development. Circ Res 2010, 106:941-951.
15. Nyqvist D., Giampietro C., Dejana E. Deciphering the functional role of endothelial junctions by using in vivo models. EMBO Rep 2008, 9:742-747.
16. Morita K., Sasaki H., Furuse M., Tsukita S. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 1999, 147:185-194.
17. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003, 161:653-660.
18. Taddei A., Giampietro C., Conti A., Orsenigo F., Breviario F., Pirazzoli V., Potente M., Daly C., Dimmeler S., Dejana E. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 2008, 10:923-934.
19. Dejana E., Taddei A., Randi A.M. Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis. Biochim Biophys Acta 2007, 1775:298-312.
20. Furuyama T., Kitayama K., Shimoda Y., Ogawa M., Sone K., Yoshida-Araki K., Hisatsune H., Nishikawa S., Nakayama K., Ikeda K., et al. Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J Biol Chem 2004, 279:34741-34749.
21. Dejana E., Orsenigo F., Lampugnani M.G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008, 121:2115-2122.
22. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985.
23. Esser S., Lampugnani M.G., Corada M., Dejana E., Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 1998, 111(Pt 13):1853-1865.
24. Wallez Y., Cand F., Cruzalegui F., Wernstedt C., Souchelnytskyi S., Vilgrain I., Huber P. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene 2007, 26:1067-1077.
25. Eliceiri B.P., Paul R., Schwartzberg P.L., Hood J.D., Leng J., Cheresh D.A. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 1999, 4:915-924.
26. Weis S., Shintani S., Weber A., Kirchmair R., Wood M., Cravens A., McSharry H., Iwakura A., Yoon Y.S., Himes N., et al. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 2004, 113:885-894.
27. Monaghan-Benson E., Burridge K. The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem 2009, 284:25602-25611.
28. Cain R.J., Vanhaesebroeck B., Ridley A.J. The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. J Cell Biol 2010, 188:863-876.
29. Potter M.D., Barbero S., Cheresh D.A. Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 2005, 280:31906-31912.
30. Turowski P., Martinelli R., Crawford R., Wateridge D., Papageorgiou A.P., Lampugnani M.G., Gamp A.C., Vestweber D., Adamson P., Dejana E., et al. Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration. J Cell Sci 2008, 121:29-37.
31. Allingham M.J., van Buul J.D., Burridge K. ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. J Immunol 2007, 179:4053-4064.
32. Nawroth R., Poell G., Ranft A., Kloep S., Samulowitz U., Fachinger G., Golding M., Shima D.T., Deutsch U., Vestweber D. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. Embo J 2002, 21:4885-4895.
33. Fachinger G., Deutsch U., Risau W. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene 1999, 18:5948-5953.
34. Baumer S., Keller L., Holtmann A., Funke R., August B., Gamp A., Wolburg H., Wolburg-Buchholz K., Deutsch U., Vestweber D. Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood 2006, 107:4754-4762.
35. Dominguez M.G., Hughes V.C., Pan L., Simmons M., Daly C., Anderson K., Noguera-Troise I., Murphy A.J., Valenzuela D.M., Davis S., et al. Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis. Proc Natl Acad Sci U S A 2007, 104:3243-3248.
36. Nottebaum A.F., Cagna G., Winderlich M., Gamp A.C., Linnepe R., Polaschegg C., Filippova K., Lyck R., Engelhardt B., Kamenyeva O., et al. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. J Exp Med 2008, 205:2929-2945.
37. Gavard J., Gutkind J.S. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 2006, 8:1223-1234.
38. Gavard J., Hou X., Qu Y., Masedunskas A., Martin D., Weigert R., Li X., Gutkind J.S. A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Mol Cell Biol 2009, 29:2469-2480.
39. Xiao K., Garner J., Buckley K.M., Vincent P.A., Chiasson C.M., Dejana E., Faundez V., Kowalczyk A.P. p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin. Mol Biol Cell 2005, 16:5141-5151.
40. Xiao K., Allison D.F., Buckley K.M., Kottke M.D., Vincent P.A., Faundez V., Kowalczyk A.P. Cellular levels of p120 catenin function as a set point for cadherin expression levels in microvascular endothelial cells. J Cell Biol 2003, 163:535-545.
41. Iyer S., Ferreri D.M., DeCocco N.C., Minnear F.L., Vincent P.A. VE-cadherin-p120 interaction is required for maintenance of endothelial barrier function. Am J Physiol Lung Cell Mol Physiol 2004, 286:L1143-1153.
42. Murakami M., Nguyen L.T., Zhuang Z.W., Moodie K.L., Carmeliet P., Stan R.V., Simons M. The FGF system has a key role in regulating vascular integrity. J Clin Invest 2008, 118:3355-3366.
43. Alcaide P., Newton G., Auerbach S., Sehrawat S., Mayadas T.N., Golan D.E., Yacono P., Vincent P., Kowalczyk A., Luscinskas F.W. p120-Catenin regulates leukocyte transmigration through an effect on VE-cadherin phosphorylation. Blood 2008, 112:2770-2779.
44. Fukuhara S., Sako K., Noda K., Zhang J., Minami M., Mochizuki N. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol 2010, 25:387-396.
45. Gavard J., Patel V., Gutkind J.S. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 2008, 14:25-36.
46. Regan-Klapisz E., Krouwer V., Langelaar-Makkinje M., Nallan L., Gelb M., Gerritsen H., Verkleij A.J., Post J.A. Golgi-associated cPLA2alpha regulates endothelial cell-cell junction integrity by controlling the trafficking of transmembrane junction proteins. Mol Biol Cell 2009, 20:4225-4234.
47. Almagro S., Durmort C., Chervin-Petinot A., Heyraud S., Dubois M., Lambert O., Maillefaud C., Hewat E., Schaal J.P., Huber P., et al. The motor protein myosin-X transports VE-cadherin along filopodia to allow the formation of early endothelial cell-cell contacts. Mol Cell Biol 2010, 30:1703-1717.
48. Gory S., Dalmon J., Prandini M.H., Kortulewski T., de Launoit Y., Huber P. Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription. J Biol Chem 1998, 273:6750-6755.
49. Lelievre E., Mattot V., Huber P., Vandenbunder B., Soncin F. ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin. Oncogene 2000, 19:2438-2446.
50. Birdsey G.M., Dryden N.H., Amsellem V., Gebhardt F., Sahnan K., Haskard D.O., Dejana E., Mason J.C., Randi A.M. Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood 2008, 111:3498-3506.
51. Visvader J.E., Fujiwara Y., Orkin S.H. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev 1998, 12:473-479.
52. Deleuze V., Chalhoub E., El-Hajj R., Dohet C., Le Clech M., Couraud P.O., Huber P., Mathieu D. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells. Mol Cell Biol 2007, 27:2687-2697.
53. Carter W.B., Niu G., Ward M.D., Small G., Hahn J.E., Muffly B.J. Mechanisms of HER2-induced endothelial cell retraction. Ann Surg Oncol 2007, 14:2971-2978.
54. Lopez D., Niu G., Huber P., Carter W.B. Tumor-induced upregulation of Twist, Snail, and Slug represses the activity of the human VE-cadherin promoter. Arch Biochem Biophys 2009, 482:77-82.
55. Conacci-Sorrell M., Simcha I., Ben-Yedidia T., Blechman J., Savagner P., Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 2003, 163:847-857.
56. Zerlin M., Julius M.A., Kitajewski J. Wnt/Frizzled signaling in angiogenesis. Angiogenesis 2008, 11:63-69.
57. Grazia Lampugnani M., Zanetti A., Corada M., Takahashi T., Balconi G., Breviario F., Orsenigo F., Cattelino A., Kemler R., Daniel T.O., et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 2003, 161:793-804.
58. Lampugnani M.G., Orsenigo F., Gagliani M.C., Tacchetti C., Dejana E. Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol 2006, 174:593-604.
59. Rudini N., Felici A., Giampietro C., Lampugnani M., Corada M., Swirsding K., Garre M., Liebner S., Letarte M., ten Dijke P., et al. VE-cadherin is a critical endothelial regulator of TGF-beta signalling. Embo J 2008, 27:993-1004.
60. Abraham S., Yeo M., Montero-Balaguer M., Paterson H., Dejana E., Marshall C.J., Mavria G. VE-cadherin-mediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation. Curr Biol 2009, 19:668-674.
61. Nelson C.M., Pirone D.M., Tan J.L., Chen C.S. Vascular endothelial-cadherin regulates cytoskeletal tension, cell spreading, and focal adhesions by stimulating RhoA. Mol Biol Cell 2004, 15:2943-2953.
62. Nelson C.M., Chen C.S. VE-cadherin simultaneously stimulates and inhibits cell proliferation by altering cytoskeletal structure and tension. J Cell Sci 2003, 116:3571-3581.
63. Lampugnani M.G., Zanetti A., Breviario F., Balconi G., Orsenigo F., Corada M., Spagnuolo R., Betson M., Braga V., Dejana E. VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Mol Biol Cell 2002, 13:1175-1189.
64. Fukuhra S., Sakurai A., Yamagishi A., Sako K., Mochizuki N. Vascular endothelial cadherin-mediated cell-cell adhesion regulated by a small GTPase, Rap1. J Biochem Mol Biol 2006, 39:132-139.
65. Glading A., Han J., Stockton R.A., Ginsberg M.H. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell-cell junctions. J Cell Biol 2007, 179:247-254.
66. Lampugnani M.G., Orsenigo F., Rudini N., Maddaluno L., Boulday G., Chapon F., Dejana E. CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J Cell Sci 2010, 123:1073-1080.
67. Beckers C.M., Garcia-Vallejo J.J., van Hinsbergh V.W., van Nieuw Amerongen G.P. Nuclear targeting of beta-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction. Cardiovasc Res 2008, 79:679-688.
68. Harris E.S., Nelson W.J. APC regulates endothelial cell migration independent of roles in {beta}-catenin signaling and cell-cell adhesion. Mol Biol Cell 2010.
69. Zhang J., O'Donnell J.J., Holian O., Vincent P.A., Kim K.S., Lum H. p120 catenin represses transcriptional activity through Kaiso in endothelial cells. Microvasc Res 2010.
70. Daniel J.M. Dancing in and out of the nucleus: p120(ctn) and the transcription factor Kaiso. Biochim Biophys Acta 2007, 1773:59-68.
71. Maretto S., Cordenonsi M., Dupont S., Braghetta P., Broccoli V., Hassan A.B., Volpin D., Bressan G.M., Piccolo S. Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci U S A 2003, 100:3299-3304.
72. Liebner S., Corada M., Bangsow T., Babbage J., Taddei A., Czupalla C.J., Reis M., Felici A., Wolburg H., Fruttiger M., et al. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol 2008, 183:409-417.
73. Daneman R., Agalliu D., Zhou L., Kuhnert F., Kuo C.J., Barres B.A. Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci U S A 2009, 106:641-646.
74. Skurk C., Maatz H., Rocnik E., Bialik A., Force T., Walsh K. Glycogen-synthase kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Circ Res 2005, 96:308-318.